169 related articles for article (PubMed ID: 36540259)
21. Diabody Pretargeting with Click Chemistry In Vivo.
van Duijnhoven SM; Rossin R; van den Bosch SM; Wheatcroft MP; Hudson PJ; Robillard MS
J Nucl Med; 2015 Sep; 56(9):1422-8. PubMed ID: 26159589
[TBL] [Abstract][Full Text] [Related]
22. Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction.
Membreno R; Cook BE; Zeglis BM
J Vis Exp; 2019 Jan; (143):. PubMed ID: 30774125
[TBL] [Abstract][Full Text] [Related]
23. Tetrazine-trans-cyclooctene ligation: Unveiling the chemistry and applications within the human body.
Tomarchio EG; Turnaturi R; Saccullo E; Patamia V; Floresta G; Zagni C; Rescifina A
Bioorg Chem; 2024 Jun; 150():107573. PubMed ID: 38905885
[TBL] [Abstract][Full Text] [Related]
24. Pretargeted Nuclear Imaging and Radioimmunotherapy Based on the Inverse Electron-Demand Diels-Alder Reaction and Key Factors in the Pretargeted Synthetic Design.
Qiu L; Mao W; Yin H; Tan H; Cheng D; Shi H
Contrast Media Mol Imaging; 2019; 2019():9182476. PubMed ID: 31531006
[TBL] [Abstract][Full Text] [Related]
25. Tetrazine Carbon Nanotubes for Pretargeted In Vivo "Click-to-Release" Bioorthogonal Tumour Imaging.
Li H; Conde J; Guerreiro A; Bernardes GJL
Angew Chem Int Ed Engl; 2020 Sep; 59(37):16023-16032. PubMed ID: 32558207
[TBL] [Abstract][Full Text] [Related]
26. A Bone-Seeking trans-Cyclooctene for Pretargeting and Bioorthogonal Chemistry: A Proof of Concept Study Using
Yazdani A; Bilton H; Vito A; Genady AR; Rathmann SM; Ahmad Z; Janzen N; Czorny S; Zeglis BM; Francesconi LC; Valliant JF
J Med Chem; 2016 Oct; 59(20):9381-9389. PubMed ID: 27676258
[TBL] [Abstract][Full Text] [Related]
27. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
[TBL] [Abstract][Full Text] [Related]
28. Pretargeting of internalizing trastuzumab and cetuximab with a
Keinänen O; Fung K; Pourat J; Jallinoja V; Vivier D; Pillarsetty NK; Airaksinen AJ; Lewis JS; Zeglis BM; Sarparanta M
EJNMMI Res; 2017 Dec; 7(1):95. PubMed ID: 29198065
[TBL] [Abstract][Full Text] [Related]
29. Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [
Lumen D; Vugts D; Chomet M; Imlimthan S; Sarparanta M; Vos R; Schreurs M; Verlaan M; Lang PA; Hippeläinen E; Beaino W; Windhorst AD; Airaksinen AJ
Bioconjug Chem; 2022 May; 33(5):956-968. PubMed ID: 35442642
[TBL] [Abstract][Full Text] [Related]
30. HPMA-Based Nanoparticles for Fast, Bioorthogonal iEDDA Ligation.
Kramer S; Svatunek D; Alberg I; Gräfen B; Schmitt S; Braun L; van Onzen AHAM; Rossin R; Koynov K; Mikula H; Zentel R
Biomacromolecules; 2019 Oct; 20(10):3786-3797. PubMed ID: 31535846
[TBL] [Abstract][Full Text] [Related]
31. Chemiluminescent probe for the detection of inverse electron demand Diels-Alder reaction between tetrazine and trans-Cyclooctene.
Wu K; Royzen M
Bioorg Med Chem; 2021 Oct; 47():116400. PubMed ID: 34530297
[TBL] [Abstract][Full Text] [Related]
32. Cascade In Situ Self-Assembly and Bioorthogonal Reaction Enable the Enrichment of Photosensitizers and Carbonic Anhydrase Inhibitors for Pretargeted Cancer Theranostics.
Wen X; Zeng W; Zhang J; Liu Y; Miao Y; Liu S; Yang Y; Xu JJ; Ye D
Angew Chem Int Ed Engl; 2024 Jan; 63(4):e202314039. PubMed ID: 38055211
[TBL] [Abstract][Full Text] [Related]
33. The inverse electron demand Diels-Alder cycloaddition with carbon-11 and fluorine-18: A gateway to pretargeted imaging across the blood-brain barrier.
Zientek SH; Thompson S; Sephton SM; Aigbirhio FI
J Labelled Comp Radiopharm; 2023 Jul; 66(9):249-268. PubMed ID: 37147795
[TBL] [Abstract][Full Text] [Related]
34. Enhanced therapeutic potential of antibody fragment via IEDDA-mediated site-specific albumin conjugation.
Go EB; Lee JH; Cho JH; Kwon NH; Choi JI; Kwon I
J Biol Eng; 2024 Apr; 18(1):23. PubMed ID: 38576037
[TBL] [Abstract][Full Text] [Related]
35. Click-Mediated Pretargeted Radioimmunotherapy of Colorectal Carcinoma.
Membreno R; Cook BE; Fung K; Lewis JS; Zeglis BM
Mol Pharm; 2018 Apr; 15(4):1729-1734. PubMed ID: 29502416
[TBL] [Abstract][Full Text] [Related]
36. (18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry.
Meyer JP; Houghton JL; Kozlowski P; Abdel-Atti D; Reiner T; Pillarsetty NV; Scholz WW; Zeglis BM; Lewis JS
Bioconjug Chem; 2016 Feb; 27(2):298-301. PubMed ID: 26479967
[TBL] [Abstract][Full Text] [Related]
37. Diels-Alder reaction for tumor pretargeting: in vivo chemistry can boost tumor radiation dose compared with directly labeled antibody.
Rossin R; Läppchen T; van den Bosch SM; Laforest R; Robillard MS
J Nucl Med; 2013 Nov; 54(11):1989-95. PubMed ID: 24092936
[TBL] [Abstract][Full Text] [Related]
38. Multivalent Albumin-Neonatal Fc Receptor Interactions Mediate a Prominent Extension of the Serum Half-Life of a Therapeutic Protein.
Yang B; Kwon I
Mol Pharm; 2021 Jun; 18(6):2397-2405. PubMed ID: 33983743
[TBL] [Abstract][Full Text] [Related]
39. IEDDA: An Attractive Bioorthogonal Reaction for Biomedical Applications.
Handula M; Chen KT; Seimbille Y
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361793
[TBL] [Abstract][Full Text] [Related]
40. Pretargeted imaging beyond the blood-brain barrier.
Shalgunov V; Lopes van den Broek S; Vang Andersen I; García Vázquez R; Raval NR; Palner M; Mori Y; Schäfer G; Herrmann B; Mikula H; Beschorner N; Nedergaard M; Syvänen S; Barz M; Moos Knudsen G; Battisti UM; Herth MM
RSC Med Chem; 2023 Mar; 14(3):444-453. PubMed ID: 36970152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
